FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Daclatasvir Tablets
Status: Discontinuation
»Therapeutic Categories: Antiviral

Expand all

Bristol Myers Squibb Co. (Revised 01/04/2019)

Company Contact Information:
800-332-2056

Presentation Posting Date Related Information
60 mg tablets (NDC 0003-0215-01) 01/04/2019 Planned cease distribution is June 2019.
30 mg tablets (NDC 0003-0213-01) 01/04/2019 Planned cease distribution is June 2019.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English